Association Between Type 2 Diabetes Mellitus and Sepsis Outcomes: A Systematic Review and Meta-Analysis
Abstract
Sepsis is a major cause of morbidity and mortality worldwide. Type 2 diabetes mellitus (T2DM) is common among adults with infection and has been proposed as a potential modifier of sepsis outcomes. This systematic review and meta-analysis aimed to evaluate the association between pre-existing T2DM and mortality among adults with sepsis. This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. PubMed, Cochrane CENTRAL, and Google Scholar databases were systematically searched from inception to April 23, 2026. Observational studies comparing outcomes in adult patients with sepsis with and without T2DM were eligible. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model. A total of 651 records were identified. Seven studies were included in the qualitative synthesis, and three in the primary quantitative meta-analysis. The pooled analysis showed no statistically significant association between T2DM and sepsis mortality (OR = 0.99; 95% CI = 0.82-1.20). However, substantial heterogeneity was observed across studies (I² = 98.4%). Sensitivity and exploratory analyses yielded similar findings. Narrative evidence suggested that glycemic status, diabetes-related complications, and acute renal dysfunction may be more important determinants of outcomes than the diagnosis of T2DM alone. The current evidence did not demonstrate a statistically significant…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.